Showing results (11-20 of 660) with videos related to

Sort By:
Pageof 66
Drug Safety|June 25, 1998
A risk-benefit assessment of irinotecan in solid tumoursL L Siu, E K Rowinsky
British Journal of Cancer|October 25, 2017
Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic reviewA Prawira, S F Oosting, T W Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Cancer Genetics and Cytogenetics|December 5, 2000
Deletion of Xq23 is a recurrent karyotypic abnormality in acute myeloid leukemiaK F Wong, L L Siu, C C So
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynxL L Siu, P M Czaykowski, I F Tannock
Pageof 66